>
Grand Theft World Podcast 291 | Union Now With Israel with Guest Mike Winner
US Offers To Ignite Sectarian War
All the ways Iran beat Trump into submission
Heads up: Apparently the government is hiding cameras inside fake utility boxes
Sodium Batteries And EVs That Power The Grid: Inside GM's Big Energy Push
NUCLEAR ENGINE - UNLIMITED LUXURY - 20 YEARS WITHOUT REFUELING
China Unveils Nuclear-Powered Floating Hub For Green Shipping
China Launches World's 1st Commercial Brain Chip, Beating Elon Musk's Neuralink!
Modular next-gen US nuclear reactor goes critical
This Company Will Add Phone, AirPod, and Smartwatch Trackers to License Plate Readers
Elon Details SpaceX AI Data Center in Space Details and Roadmap

Date:
January 12, 2017
Source:
Buck Institute for Research on Aging
Summary:
One of the challenges in developing stem cell therapies is ensuring that transplanted cells can survive long enough to work. Researchers report one of the first demonstrations of long-term vision restoration in blind mice by transplanting photoreceptors derived from human stem cells and blocking the immune response that causes transplanted cells to be rejected. The findings support a path to improving clinical applications in restoring human vision lost to degenerative eye diseases.